Ascentage Pharma Group International Balance Sheet (2022-2025) | AAPG

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2022 Dec2023 Dec2024 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 189.20M3.41M124.33M231.93M348.26M
Cash & Current Investments (Quarter) 189.20M3.41M124.33M231.93M348.26M
Receivables - Net (Quarter) 20.26M11.57M10.94M35.66M
Receivables - Other (Quarter) 0.92M0.85M0.21M
Receivables (Quarter) 21.18M12.43M10.94M35.87M
Work In Process (Quarter) 0.71M0.38M3.58M
Finished Goods (Quarter) 1.54M0.54M1.05M
Inventory (Quarter) 2.25M0.92M1.20M4.03M
Current Deferred Tax Assets (Quarter) 56.94M42.82M93.45M183.40M
Prepaid Assets (Quarter) 0.70M17.15M22.38M4.60M
Current Assets (Quarter) 186.69M205.23M266.45M415.11M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 49.97M125.81M118.26M114.64M110.15M
Long-Term Investments (Quarter) 2.36M0.16M0.65M0.56M
Goodwill (Quarter) 3.43M3.44M3.45M3.48M
Intangibles (Quarter) 4.02M3.77M10.58M9.91M9.30M
Goodwill & Intangibles (Quarter) 4.02M7.20M14.02M13.36M12.78M
Long-Term Deferred Tax (Quarter) 8.38M2.28M6.16M4.66M4.51M
Other Non-Current Assets (Quarter) 0.02M8.26M13.83M4.33M
Non-Current Assets (Quarter) 160.58M159.21M158.78M143.73M
Assets (Quarter) 347.27M364.44M425.23M558.84M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 10.06M12.80M16.57M15.05M
Payables (Quarter) 10.06M12.80M16.57M15.05M
Accumulated Expenses (Quarter) 0.57M2.07M34.81M0.38M
Current Leases (Quarter) 1.36M1.31M1.03M
Current Deferred Revenue (Quarter) 40.22M5.22M5.23M34.93M
Total Current Liabilities (Quarter) 129.74M162.41M252.22M231.70M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter) 5.05M34.59M0.92M
Minority Interest (Quarter) 1.42M1.39M
Non-Current Deferred Tax Liability (Quarter) 2.46M2.22M1.68M1.81M
Operating Leases (Quarter) 2.42M3.15M4.21M3.13M
Other Non-Current Liabilities (Quarter) 2.54M0.87M1.06M1.70M
Total Non-Current Liabilities (Quarter) 207.72M163.86M424.17M139.02M
Total Liabilities (Quarter) 337.46M326.27M425.23M370.72M
Shareholder's Equity
Common Equity (Quarter) 57.46M9.81M38.17M186.74M
Liabilities and Shareholders Equity (Quarter) 347.27M364.44M425.23M558.84M
Treasury Shares (Quarter) 2.97M0.00M0.42M
Retained Earnings (Quarter) -745.15M-803.35M-988.83M